Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 271
Filter
1.
Int J Mol Sci ; 23(10)2022 May 16.
Article in English | MEDLINE | ID: mdl-35628371

ABSTRACT

Menopause is associated with memory deficits attributed to reduced serum estrogen levels. We evaluated whether an increase in brain-derived neurotrophic factor (BDNF) and nerve-growth factor (NGF) levels, through transplantation of choline acetyltransferase (ChAT)-overexpressing neural stem cells (F3.ChAT), improved learning and memory in ovariectomized rats. PD13 mouse neuronal primary culture cells were treated with estradiol or co-cultured with F3.ChAT cells; choline transporter1 (CHT1), ChAT, and vesicular acetylcholine transporter (VAChT) expression was evaluated using real-time PCR. The relationship between estrogen receptors (ERs) and neurotrophin family members was analyzed using immunohistochemistry. After the transplantation of F3.ChAT cells into OVx rats, we evaluated the memory, ACh level, and the expression of ER, neurotrophin family proteins, and cholinergic system. Estradiol upregulated CHT1, ChAT, and VAChT expression in ER; they were co-localized with BDNF, NGF, and TrkB. Co-culture with F3.ChAT upregulated CHT1, ChAT, and VAChT by activating the neurotrophin signalling pathway. Transplantation of F3.ChAT cells in OVX animals increased the ACh level in the CSF and improved memory deficit. In addition, it increased the expression of ERs, neurotrophin signaling, and the cholinergic system in the brains of OVX animals. Therefore, the estradiol deficiency induced memory loss by the down-regulation of the neurotrophin family and F3.ChAT could ameliorate the cognitive impairment owing to the loss or reduction of estradiol.


Subject(s)
Brain-Derived Neurotrophic Factor , Choline O-Acetyltransferase , Cognition , Neural Stem Cells , Acetylcholine/metabolism , Animals , Brain-Derived Neurotrophic Factor/genetics , Brain-Derived Neurotrophic Factor/metabolism , Choline/metabolism , Choline O-Acetyltransferase/biosynthesis , Choline O-Acetyltransferase/genetics , Choline O-Acetyltransferase/metabolism , Cholinergic Agents/metabolism , Cognition/physiology , Estradiol/metabolism , Humans , Memory Disorders/metabolism , Mice , Nerve Growth Factor/genetics , Nerve Growth Factor/metabolism , Neural Stem Cells/cytology , Neural Stem Cells/metabolism , Rats , Vesicular Acetylcholine Transport Proteins/metabolism
2.
J Neurochem ; 158(6): 1320-1333, 2021 09.
Article in English | MEDLINE | ID: mdl-33301603

ABSTRACT

One of the urgent tasks of neuroscience is to understand how neuronal circuits operate, what makes them fail, and how to repair them when needed. Achieving this goal requires identifying the principal circuitry elements and their interactions with one another. However, what constitutes 'an atom' of a neuronal circuit, a neuronal type, is a complex question. In this review we focus on a class of cortical neurons that are exclusively identified by the expression of vasoactive intestinal polypeptide (VIP) and choline acetyltransferase (ChAT). The genetic profile of these VIP+ /ChAT+ interneurons suggests that they can release both γ-aminobutyric acid (GABA) and acetylcholine (ACh). This hints to a specific potential role in the cortical circuitry. Yet the VIP+ /ChAT+ interneurons are sparse (a mere 0.5% of the cortical neurons), which raises questions about their potential to significantly affect the circuit function. In view of recent developments in genetic techniques that allow for direct manipulation of these neurons, we provide a thorough and updated picture of the properties of the VIP+ /ChAT+ interneurons. We discuss their genetic profile, their physiological and structural properties, and their input-output mapping in sensory cortices and the medial prefrontal cortex (mPFC). Then, we examine possible amplification mechanisms for mediating their function in the cortical microcircuit. Finally, we discuss directions for further exploration of the VIP+ /ChAT+ population, focusing on its function during behavioral tasks as compared to the VIP+ /ChAT- population.


Subject(s)
Cerebral Cortex/metabolism , Choline O-Acetyltransferase/biosynthesis , Choline O-Acetyltransferase/genetics , Interneurons/metabolism , Vasoactive Intestinal Peptide/biosynthesis , Vasoactive Intestinal Peptide/genetics , Animals , Cerebral Cortex/chemistry , Choline O-Acetyltransferase/analysis , Humans , Interneurons/chemistry , Transcriptome/physiology , Vasoactive Intestinal Peptide/analysis
3.
Int J Mol Sci ; 22(11)2021 May 23.
Article in English | MEDLINE | ID: mdl-34071104

ABSTRACT

Dorsal root ganglia (DRG) neurons synthesize acetylcholine (ACh), in addition to their peptidergic nature. They also release ACh and are cholinoceptive, as they express cholinergic receptors. During gangliogenesis, ACh plays an important role in neuronal differentiation, modulating neuritic outgrowth and neurospecific gene expression. Starting from these data, we studied the expression of choline acetyltransferase (ChAT) and vesicular ACh transporter (VAChT) expression in rat DRG neurons. ChAT and VAChT genes are arranged in a "cholinergic locus", and several splice variants have been described. Using selective primers, we characterized splice variants of these cholinergic markers, demonstrating that rat DRGs express R1, R2, M, and N variants for ChAT and V1, V2, R1, and R2 splice variants for VAChT. Moreover, by RT-PCR analysis, we observed a progressive decrease in ChAT and VAChT transcripts from the late embryonic developmental stage (E18) to postnatal P2 and P15 and in the adult DRG. Interestingly, Western blot analyses and activity assays demonstrated that ChAT levels significantly increased during DRG ontogenesis. The modulated expression of different ChAT and VAChT splice variants during development suggests a possible differential regulation of cholinergic marker expression in sensory neurons and confirms multiple roles for ACh in DRG neurons, both in the embryo stage and postnatally.


Subject(s)
Choline O-Acetyltransferase/biosynthesis , Cholinergic Neurons/metabolism , Ganglia, Spinal/cytology , Nerve Tissue Proteins/biosynthesis , Sensory Receptor Cells/metabolism , Vesicular Acetylcholine Transport Proteins/biosynthesis , Acetylcholine/metabolism , Alternative Splicing , Animals , Choline O-Acetyltransferase/genetics , Cholinergic Neurons/cytology , Ganglia, Spinal/embryology , Ganglia, Spinal/growth & development , Nerve Tissue Proteins/genetics , Neurogenesis , Protein Isoforms/biosynthesis , Protein Isoforms/genetics , Rats , Rats, Wistar , Reverse Transcriptase Polymerase Chain Reaction , Sensory Receptor Cells/cytology , Synaptic Vesicles/metabolism , Vesicular Acetylcholine Transport Proteins/genetics
4.
Int J Mol Sci ; 21(14)2020 Jul 11.
Article in English | MEDLINE | ID: mdl-32664537

ABSTRACT

BACKGROUND: Trimethyltin (TMT) is a potent neurotoxin affecting various regions of the central nervous system, including the neocortex, the cerebellum, and the hippocampus. Phosphatidylserine (PS) is a membrane phospholipid, which is vital to brain cells. We analyzed the neuroprotective effects of soybean-derived phosphatidylserine (Bean-PS) on cognitive function, changes in the central cholinergic systems, and neural activity in TMT-induced memory deficits in a rat model. METHODS: The rats were randomly divided into an untreated normal group, a TMT group (injected with TMT + vehicle), and a group injected with TMT + Bean-PS. The rats were treated with 10% hexane (TMT group) or TMT + Bean-PS (50 mg·kg-1, oral administration (p.o.)) daily for 21 days, following a single injection of TMT (8.0 mg/kg, intraperitoneally (i.p.)). The cognitive function of Bean-PS was assessed using the Morris water maze (MWM) test and a passive avoidance task (PAT). The expression of acetylcholine transferase (ChAT) and acetylcholinesterase (AchE) in the hippocampus was assessed via immunohistochemistry. A positron emission tomography (PET) scan was used to measure the glucose uptake in the rat brain. RESULTS: Treatment with Bean-PS enhanced memory function in the Morris water maze (MWM) test. Consistent with the behavioral results, treatment with Bean-PS diminished the damage to cholinergic cells in the hippocampus, in contrast to those of the TMT group. The TMT+Bean-PS group showed elevated glucose uptake in the frontal lobe of the rat brain. CONCLUSION: These results demonstrate that Bean-PS protects against TMT-induced learning and memory impairment. As such, Bean-PS represents a potential treatment for neurodegenerative disorders, such as Alzheimer's disease.


Subject(s)
Cognition Disorders/prevention & control , Neuroprotective Agents/therapeutic use , Phosphatidylserines/therapeutic use , Acetylcholinesterase/biosynthesis , Acetylcholinesterase/genetics , Animals , Avoidance Learning/drug effects , Brain/diagnostic imaging , Brain/metabolism , Choline O-Acetyltransferase/biosynthesis , Choline O-Acetyltransferase/genetics , Cognition Disorders/chemically induced , Escape Reaction/drug effects , Glucose/pharmacokinetics , Hippocampus/drug effects , Hippocampus/metabolism , Male , Morris Water Maze Test/drug effects , Nerve Tissue Proteins/biosynthesis , Nerve Tissue Proteins/genetics , Neuroprotective Agents/pharmacology , Phosphatidylserines/pharmacology , Positron-Emission Tomography , Random Allocation , Rats , Rats, Sprague-Dawley , Glycine max/chemistry , Trimethyltin Compounds/toxicity
5.
J Biol Regul Homeost Agents ; 32(4): 803-813, 2018.
Article in English | MEDLINE | ID: mdl-30043562

ABSTRACT

Spinal cord ischemia-reperfusion injury (IRI) results in overproduction of reactive oxygen species leading to tissue oxidative stress which impacts the neuronal network in the spinal cord as well as glial cells. We investigated the expression of Nuclear factor erythroid 2-related factor 2 (Nrf2) in neurons and glial cells after occlusion of the abdominal aorta followed by IRI as well as the time-dependent expression of Nrf2 in the same cells. The experimental method of transient aortic occlusion was carried out on rats by cross-clamping of the abdominal aorta for 45 minutes. The animals used for this study were sacrificed 1 h, 6 h, and 48 h after reperfusion to determine time-related changes of Nrf2 expression, as well as changes of astrocyte activity in the spinal cord. Immunofluorescence results showed an increase in the staining intensity of Nrf2 expression in the neurons following ischemia with highest intensity 48 h post-reperfusion and an increase in a number of reactive astrocytes. Western blot analysis showed that Nrf2 protein expression increased in a cytoplasmic and nuclear fraction as early as 1 h after reperfusion and remained active 48 h after, resulting in increased expression of the main Nrf2 target gene HO-1. In conclusion, substances that enhance expression of Nrf2 may have the potential to prevent cellular damage to the spinal cord caused by IRI.


Subject(s)
Choline O-Acetyltransferase/biosynthesis , NF-E2-Related Factor 2/biosynthesis , Reperfusion Injury/metabolism , Spinal Cord Ischemia/metabolism , Animals , Male , Neurons/metabolism , Neurons/pathology , Oxidative Stress/physiology , Rats , Rats, Wistar , Reperfusion Injury/physiopathology , Spinal Cord Ischemia/physiopathology
6.
J Neurosci ; 36(50): 12661-12676, 2016 12 14.
Article in English | MEDLINE | ID: mdl-27810937

ABSTRACT

Cytoplasmic polyadenylation element binding protein 2 (CPEB2) is an RNA-binding protein and translational regulator. To understand the physiological function of CPEB2, we generated CPEB2 knock-out (KO) mice and found that most died within 3 d after birth. CPEB2 is highly expressed in the brainstem, which controls vital functions, such as breathing. Whole-body plethysmography revealed that KO neonates had aberrant respiration with frequent apnea. Nevertheless, the morphology and function of the respiratory rhythm generator and diaphragm neuromuscular junctions appeared normal. We found that upregulated translation of choline acetyltransferase in the CPEB2 KO dorsal motor nucleus of vagus resulted in hyperactivation of parasympathetic signaling-induced bronchoconstriction, as evidenced by increased pulmonary acetylcholine and phosphorylated myosin light chain 2 in bronchial smooth muscles. Specific deletion of CPEB2 in cholinergic neurons sufficiently caused increased apnea in neonatal pups and airway hyper-reactivity in adult mice. Moreover, inhalation of an anticholinergic bronchodilator reduced apnea episodes in global and cholinergic CPEB2-KO mice. Together, the elevated airway constriction induced by cholinergic transmission in KO neonates may account for the respiratory defect and mortality. SIGNIFICANCE STATEMENT: This study first generated and characterized cpeb2 gene-deficient mice. CPEB2-knock-out (KO) mice are born alive but most die within 3 d after birth showing no overt defects in anatomy. We found that the KO neonates showed severe apnea and altered respiratory pattern. Such respiratory defects could be recapitulated in mice with pan-neuron-specific or cholinergic neuron-specific ablation of the cpeb2 gene. Further investigation revealed that cholinergic transmission in the KO dorsal motor nucleus of vagus was overactivated because KO mice lack CPEB2-suppressed translation of the rate-limiting enzyme in the production of acetylcholine (i.e., choline acetyltransferase). Consequently, increased parasympathetic signaling leads to hyperactivated bronchoconstriction and abnormal respiration in the KO neonates.


Subject(s)
Bronchoconstriction/physiology , Choline O-Acetyltransferase/biosynthesis , Parasympathetic Nervous System/physiology , RNA-Binding Proteins/genetics , Signal Transduction/physiology , Vagus Nerve/enzymology , Animals , Bronchoconstriction/drug effects , Bronchodilator Agents/pharmacology , Diaphragm/innervation , Diaphragm/physiology , Female , Genotype , Lung/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Muscle, Smooth/physiology , Neuromuscular Junction/physiology , Parasympathetic Nervous System/drug effects , Respiratory Mechanics/physiology , Signal Transduction/drug effects , Up-Regulation , Vagus Nerve/drug effects
7.
Neurochem Res ; 41(8): 2065-74, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27113041

ABSTRACT

Lineage specific human embryonic stem cell (hESC) reporter cell line is a versatile tool for biological studies on real time monitoring of differentiation, physiological and biochemical features of special cell types and pathological mechanism of disease. Here we report the generation of ChAT-zsGreen reporter hESC line that express zsGreen under the control of the choline acetyltransferase (ChAT) promoter using CRISPR (Clustered Regularly Interspersed Short Palindromic Repeats)/Cas9 system. We show that the ChAT-zsGreen hESC reporter cell lines retain the features of undifferentiated hESC. After cholinergic neuronal differentiation, cholinergic neurons were clearly labeled with green fluorescence protein (zsGreen). The ChAT-zsGreen reporter hESC lines are invaluable not only for the monitoring cholinergic neuronal differentiation but also for study physiological and biochemical hallmarks of cholinergic neurons.


Subject(s)
CRISPR-Cas Systems/physiology , Cholinergic Neurons/metabolism , Genes, Reporter/physiology , Green Fluorescent Proteins/biosynthesis , Human Embryonic Stem Cells/metabolism , Cell Line , Choline O-Acetyltransferase/biosynthesis , Choline O-Acetyltransferase/genetics , Green Fluorescent Proteins/genetics , Humans
8.
Int J Mol Sci ; 17(12)2016 Dec 01.
Article in English | MEDLINE | ID: mdl-27916956

ABSTRACT

Neurotrophins play a principal role in neuronal survival and differentiation during development, but also in the maintenance of appropriate adult neuronal circuits and phenotypes. In the oculomotor system, we have demonstrated that neurotrophins are key regulators of developing and adult neuronal properties, but with peculiarities depending on each neurotrophin. For instance, the administration of NGF (nerve growth factor), BDNF (brain-derived neurotrophic factor) or NT-3 (neurotrophin-3) protects neonatal extraocular motoneurons from cell death after axotomy, but only NGF and BDNF prevent the downregulation in ChAT (choline acetyltransferase). In the adult, in vivo recordings of axotomized extraocular motoneurons have demonstrated that the delivery of NGF, BDNF or NT-3 recovers different components of the firing discharge activity of these cells, with some particularities in the case of NGF. All neurotrophins have also synaptotrophic activity, although to different degrees. Accordingly, neurotrophins can restore the axotomy-induced alterations acting selectively on different properties of the motoneuron. In this review, we summarize these evidences and discuss them in the context of other motor systems.


Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Motor Neurons/metabolism , Nerve Growth Factor/metabolism , Nerve Growth Factors/metabolism , Animals , Axotomy , Brain-Derived Neurotrophic Factor/pharmacology , Cell Death/drug effects , Choline O-Acetyltransferase/biosynthesis , Choline O-Acetyltransferase/genetics , Gene Expression Regulation, Developmental/drug effects , Humans , Motor Neurons/drug effects , Nerve Growth Factor/pharmacology , Nerve Growth Factors/pharmacology , Neurotrophin 3
9.
Biochem J ; 460(3): 437-46, 2014 Jun 15.
Article in English | MEDLINE | ID: mdl-24673421

ABSTRACT

Lack of permissive mechanisms and abundance of inhibitory molecules in the lesioned central nervous system of adult mammals contribute to the failure of functional recovery, which leads to severe disabilities in motor functions or pain. Previous studies have indicated that the neural cell adhesion molecule L1 constitutes a viable target to promote regeneration. In the present study, we describe the cloning, functional expression in Escherichia coli cells and purification of a recombinant αL1 Fab fragment that binds to L1 with comparable activity as the function-triggering monoclonal antibody 557.B6 and induces neurite outgrowth and neuronal survival in cultured neurons, despite its monovalent function. Infusion of αL1 Fab into the lesioned spinal cord of mice enhanced functional recovery after thoracic spinal cord compression injury. αL1 Fab treatment resulted in reduced scar volume, enhanced number of tyrosine hydroxylase-positive axons and increased linear density of VGLUT1 (vesicular glutamate transporter 1) on motoneurons. Furthermore, the number and soma size of ChAT (choline acetyltransferase)-positive motoneurons and the linear density of ChAT-positive boutons on motoneurons as well as parvalbumin-positive interneurons in the lumbar spinal cord were elevated. Stimulation of endogenous L1 by application of the αL1 Fab opens new avenues for recombinant antibody technology, offering prospects for therapeutic applications after traumatic nervous system lesions.


Subject(s)
Immunoglobulin Fab Fragments/therapeutic use , Neural Cell Adhesion Molecule L1/physiology , Recovery of Function/physiology , Spinal Cord Injuries/therapy , Animals , Antibodies, Monoclonal/therapeutic use , Choline O-Acetyltransferase/biosynthesis , Female , Mice , Mice, Inbred C57BL , Motor Neurons/metabolism , Nerve Regeneration , Neurites/physiology , Rats , Recombinant Proteins/therapeutic use , Spinal Cord Injuries/physiopathology , Vesicular Glutamate Transport Protein 1/biosynthesis
10.
Metab Brain Dis ; 30(3): 803-11, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25514862

ABSTRACT

Diabetes mellitus is a chronic metabolic disorder and has been associated with cognitive dysfunction. In our earlier study, chronic Urtica dioica (UD) treatment significantly ameliorated diabetes induced associative and spatial memory deficit in mice. The present study was designed to explore the effect of UD leaves extract on muscarinic cholinergic system, which has long been known to be involved in cognition. Streptozotocin (STZ) (50 mg/kg, i.p., consecutively for 5 days) was used to induce diabetes followed by treatment with UD extract (50 mg/kg, oral) or rosiglitazone (5 mg/kg, oral) for 8 weeks. STZ-induced diabetic mice showed significant reduction in hippocampal muscarinic acetylcholine receptor-1 and choline acetyltransferase expressions. Chronic diabetes significantly up-regulated the protein expression of acetylcholinesterase associated with oxidative stress in hippocampus. Besides, STZ-induced diabetic mice showed hypolocomotion with up-regulation of muscarinic acetylcholine receptor-4 expression in striatum. Chronic UD treatment significantly attenuated the cholinergic dysfunction and oxidative stress in the hippocampus of diabetic mice. UD had no effect on locomotor activity and muscarinic acetylcholine receptor-4 expression in striatum. In conclusion, UD leaves extract has potential to reverse diabetes mediated alteration in muscarinic cholinergic system in hippocampus and thereby improve memory functions.


Subject(s)
Choline O-Acetyltransferase/biosynthesis , Diabetes Mellitus, Experimental/metabolism , Hippocampus/metabolism , Plant Extracts/therapeutic use , Receptor, Muscarinic M1/biosynthesis , Urtica dioica , Animals , Choline O-Acetyltransferase/antagonists & inhibitors , Diabetes Mellitus, Experimental/drug therapy , Hippocampus/drug effects , Male , Mice , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Plant Leaves , Receptor, Muscarinic M1/antagonists & inhibitors , Streptozocin
11.
Cell Tissue Res ; 356(2): 319-32, 2014 May.
Article in English | MEDLINE | ID: mdl-24728885

ABSTRACT

The substance P neurokinin 1 receptor (NK1R) regulates motility, secretion, inflammation and pain in the intestine. The distribution of the NK1R is a key determinant of the functional effects of substance P in the gut. Information regarding the distribution of NK1R in subtypes of mouse enteric neurons is lacking and is the focus of the present study. NK1R immunoreactivity (NK1R-IR) is examined in whole-mount preparations of the mouse distal colon by indirect immunofluorescence and confocal microscopy. The distribution of NK1R-IR within key functional neuronal subclasses was determined by using established neurochemical markers. NK1R-IR was expressed by a subpopulation of myenteric and submucosal neurons; it was mainly detected in large multipolar myenteric neurons and was colocalized with calcitonin gene-related peptide, neurofilament M, choline acetyltransferase and calretinin. The remaining NK1R-immunoreactive neurons were positive for nitric oxide synthase. NK1R was expressed by most of the submucosal neurons and was exclusively co-expressed with vasoactive intestinal peptide, with no overlap with choline acetyltransferase. Treatment with substance P resulted in the concentration-dependent internalisation of NK1R from the cell surface into endosome-like structures. Myenteric NK1R was mainly expressed by intrinsic primary afferent neurons, with minor expression by descending interneurons and inhibitory motor neurons. Submucosal NK1R was restricted to non-cholinergic secretomotor neurons. These findings highlight key differences in the neuronal distribution of NK1R-IR between the mouse, rat and guinea-pig, with important implications for the functional role of NK1R in regulating intestinal motility and secretion.


Subject(s)
Colon/innervation , Enteric Nervous System/metabolism , Receptors, Neurokinin-1/metabolism , Substance P/metabolism , Animals , Antibodies/immunology , Calbindin 2/metabolism , Calcitonin Gene-Related Peptide/metabolism , Choline O-Acetyltransferase/biosynthesis , Colon/metabolism , Female , Fluorescent Antibody Technique, Indirect , Gastrointestinal Tract/innervation , Male , Mice , Mice, Inbred C57BL , Neurofilament Proteins/metabolism , Nitric Oxide Synthase/metabolism , Receptors, Neurokinin-1/biosynthesis , Receptors, Neurokinin-1/immunology , Vasoactive Intestinal Peptide/biosynthesis
12.
J Biomed Sci ; 21: 51, 2014 May 24.
Article in English | MEDLINE | ID: mdl-24885898

ABSTRACT

BACKGROUND: Excessive manganese exposure induced cognitive deficit. Several lines of evidence have demonstrated that taurine improves cognitive impairment induced by numerous neurotoxins. However, the role of taurine on manganese-induced damages in learning and memory is still elusive. This goal of this study was to investigate the beneficial effect of taurine on learning and memory capacity impairment by manganese exposure in an animal model. RESULTS: The escape latency in the Morris Water Maze test was significantly longer in the rats injected with manganese than that in the rats received both taurine and manganese. Similarly, the probe trial showed that the annulus crossings were significantly greater in the taurine plus manganese treated rats than those in the manganese-treated rats. However, the blood level of manganese was not altered by the taurine treatment. Interestingly, the exposure of manganese led to a significant increase in the acetylcholinesterase activity and an evidently decrease in the choline acetyltransferase activity, which were partially restored by the addition of taurine. Additionally, we identified 9 differentially expressed proteins between the rat hippocampus treated by manganese and the control or the manganese plus taurine in the proteomic analysis using the 2-dimensional gel electrophoresis followed by the tandem mass spectrometry (MS/MS). Most of these proteins play a role in energy metabolism, oxidative stress, inflammation, and neuron synapse. CONCLUSIONS: In summary, taurine restores the activity of AChE and ChAT, which are critical for the regulation of acetylcholine. We have identified seven differentially expressed proteins specifically induced by manganese and two proteins induced by taurine from the rat hippocampus. Our results support that taurine improves the impaired learning and memory ability caused by excessive exposure of manganese.


Subject(s)
Acetylcholinesterase/biosynthesis , Choline O-Acetyltransferase/biosynthesis , Learning/drug effects , Memory/drug effects , Taurine/administration & dosage , Acetylcholine/metabolism , Animals , Brain/drug effects , Brain/metabolism , Hippocampus/metabolism , Humans , Manganese/toxicity , Neurons/drug effects , Neurons/metabolism , Rats , Tandem Mass Spectrometry
13.
Biol Pharm Bull ; 37(5): 826-33, 2014.
Article in English | MEDLINE | ID: mdl-24599032

ABSTRACT

In Alzheimer's disease (AD), extensive neuronal loss and a deficiency of the neurotransmitter acetylcholine (ACh) are the major characteristics during pathogenesis in the brain. In the present study, we aimed to investigate whether representative ginsenosides from ginseng can regulate choline acetyltransferase (ChAT) and vesicular acetylcholine transporter (VAChT), which are required for cholinergic neurotransmission. Our results revealed that Re and Rd induced effectively the expression of ChAT/VAChT genes in Neuro-2a cells as well as ACh elevation. Microtubule-associated protein-2 (MAP-2), nerve growth factor receptor (p75), p21, and TrkA genes and proteins were also significantly expressed. Moreover, both activated extracelullar signal-regulated protein kinase (ERK) and Akt were inhibited by K252a, a selective Trk receptor inhibitor. These findings strongly indicate that Re and Rd play an important role in neuronal differentiation and the nerve growth factor (NGF)-TrkA signaling pathway. High performance liquid chromatography analysis showed that Re and Rd administered orally were transported successfully into brain tissue and increased the level of ChAT and VAChT mRNA. The present study demonstrates that Re and Rd are selective candidates for upregulation of the expression of cholinergic markers, which may counter the symptoms and progress of AD.


Subject(s)
Acetylcholine/biosynthesis , Cell Differentiation/drug effects , Gene Expression Regulation/drug effects , Ginsenosides/pharmacology , Neurons/cytology , Neurons/drug effects , Animals , Biomarkers/metabolism , Cell Line , Choline O-Acetyltransferase/biosynthesis , Ginsenosides/pharmacokinetics , Mice , Microtubule-Associated Proteins/biosynthesis , Neurons/metabolism , Receptor, Nerve Growth Factor/biosynthesis , Receptor, trkA/biosynthesis , Vesicular Acetylcholine Transport Proteins/biosynthesis , rho GTP-Binding Proteins/biosynthesis
14.
Int J Neurosci ; 124(2): 117-24, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23848990

ABSTRACT

OBJECTIVE: To observe the effect of pregnenolone (PREG) intervention on the cholinergic system function and the synaptic protein 1 (SYP1) expression in different brain regions of aged rats. METHOD: Twenty-four-month-old male Sprague Dawley rats intraperitoneally injected every other day for one month were divided into blank control group, solvent control group, PREG (0.5 mg/kg) intervention group and PREG (2.0 mg/kg) intervention group. The rats were sacrificed 2 d after the intervention and the corresponding regions of brain tissue were separated and cryopreserved. Western blot analysis was used to detect the expression level of choline acetyltransferase (ChAT), SYP1, serum PREG and the activity of ChAT and acetylcholinesterase (AChE) in different brain regions. In addition, the semiquantitative changes in the expression level of ChAT and SYP1 in frontal lobe and hippocampus were tested by immunohistochemistry. RESULT: Western blot and immunohistochemistry analysis showed that PREG (2.0 mg/kg) administration led to a significant increase of ChAT and SYP1 expressions in frontal lobe, temporal lobe, and hippocampus regions (p < 0.05). The result of enzyme-linked immunosorbent assay showed that PREG (2.0 mg/kg) administration significantly increased ChAT activity and serum PREG levels and caused a decrease in AChE activity (p < 0.05); while PREG (0.5 mg/kg) only elevated levels of serum PREG. CONCLUSION: PREG significantly improved the synaptic plasticity of memory-related brain areas of aged rats, significantly increased brain cholinergic activity and thus helps to improve learning and memory in aged rats.


Subject(s)
Aging/drug effects , Cholinergic Neurons/drug effects , Pregnenolone/pharmacology , Synapsins/biosynthesis , Acetylcholinesterase/biosynthesis , Aging/metabolism , Animals , Choline O-Acetyltransferase/biosynthesis , Cholinergic Neurons/metabolism , Dose-Response Relationship, Drug , Frontal Lobe/drug effects , Frontal Lobe/metabolism , Hippocampus/drug effects , Hippocampus/metabolism , Male , Pregnenolone/blood , Rats , Temporal Lobe/metabolism
15.
Biochem Cell Biol ; 91(5): 350-6, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24032686

ABSTRACT

Molecular processes regulating cholinergic functions play an important role in the control of respiration under hypoxia. Cholinergic alterations and its further complications in respiration due to hypoxic insult in neonatal rats and the effect of glucose, oxygen, and epinephrine resuscitation was evaluated in the present study. Receptor binding and gene expression studies were done in the corpus striatum to analyse the changes in total muscarinic receptors, muscarinic M1, M2, M3 receptors, and the enzymes involved in acetylcholine metabolism, choline acetyltransferase and acetylcholinesterase. Neonatal hypoxia decreased total muscarinic receptors with reduced expression of muscarinic M1, M2, and M3 receptor genes. The reduction in acetylcholine metabolism is indicated by the downregulated choline acetyltransferase and upregulated acetyl cholinesterase expression. These cholinergic disturbances were reversed to near control in glucose-resuscitated hypoxic neonates. The adverse effects of immediate oxygenation and epinephrine administration are also reported. The present findings points to the cholinergic alterations due to neonatal hypoxic shock and suggests a proper resuscitation method to ameliorate these striatal changes.


Subject(s)
Corpus Striatum/metabolism , Fetal Hypoxia/metabolism , Receptor, Muscarinic M1/metabolism , Receptor, Muscarinic M2/metabolism , Receptor, Muscarinic M3/metabolism , Acetylcholine/metabolism , Acetylcholinesterase/biosynthesis , Animals , Choline O-Acetyltransferase/biosynthesis , Epinephrine/metabolism , Glucose/metabolism , Oxygen/metabolism , Rats , Rats, Wistar
16.
Brain Behav Immun ; 33: 90-101, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23777652

ABSTRACT

Multiple sclerosis (MS) is a progressive T cell-mediated autoimmune demyelinating inflammatory disease of the central nervous system (CNS). Although it is recognized that cognitive deficits represent a manifestation of the disease, the underlying pathogenic mechanisms remain unknown. Here we provide evidence of spatial reference memory impairments during the pre-motor phase of experimental autoimmune encephalomyelitis (EAE) in mice. Specifically, these cognitive deficits were accompanied by down-regulation of choline acetyltransferase (ChAT) mRNA expression on day 5 and 11 post-immunization, and up-regulation of inflammatory cytokines in the hippocampus and prefrontal cortex. Moreover, a marked increase in B1R mRNA expression occurred selectively in the hippocampus, whereas protein level was up-regulated in both brain areas. Genetic deletion of kinin B1R attenuated cognitive deficits and cholinergic dysfunction, and blocked mRNA expression of both IL-17 and IFN-γ in the prefrontal cortex, lymph node and spleen of mice subjected to EAE. The discovery of kinin receptors, mainly B1R, as a target for controlling neuroinflammatory response, as well as the cognitive deficits induced by EAE may foster the therapeutic exploitation of the kallikrein-kinin system (KKS), in particular for the treatment of autoimmune disorders, such as MS, mainly during pre-symptomatic phase.


Subject(s)
Encephalomyelitis, Autoimmune, Experimental/immunology , Encephalomyelitis, Autoimmune, Experimental/physiopathology , Kallikrein-Kinin System/immunology , Memory Disorders/immunology , Memory Disorders/physiopathology , Movement Disorders/immunology , Movement Disorders/physiopathology , Spatial Behavior , Animals , Choline O-Acetyltransferase/antagonists & inhibitors , Choline O-Acetyltransferase/biosynthesis , Down-Regulation/genetics , Down-Regulation/immunology , Encephalomyelitis, Autoimmune, Experimental/genetics , Female , Hippocampus/enzymology , Hippocampus/immunology , Hippocampus/pathology , Interferon-gamma/antagonists & inhibitors , Interferon-gamma/genetics , Interleukin-17/antagonists & inhibitors , Interleukin-17/genetics , Kallikrein-Kinin System/genetics , Memory Disorders/genetics , Mice , Mice, 129 Strain , Mice, Inbred C57BL , Mice, Knockout , Movement Disorders/genetics , RNA, Messenger/antagonists & inhibitors , RNA, Messenger/biosynthesis , Random Allocation , Receptor, Bradykinin B1/deficiency , Receptor, Bradykinin B1/genetics , Receptor, Bradykinin B2/agonists , Receptor, Bradykinin B2/deficiency , Receptor, Bradykinin B2/genetics , Up-Regulation/genetics , Up-Regulation/immunology
17.
Neurochem Res ; 38(10): 2201-15, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23949198

ABSTRACT

This study investigated the effects of alcoholic extract of Bacopa monnieri (L.) Wettst. (BM) on cognitive deficits using olfactory bulbectomized (OBX) mice and the underlying molecular mechanisms of its action. OBX mice were treated daily with BM (50 mg/kg, p.o.) or a reference drug, tacrine (2.5 mg/kg, i.p.), 1 week before and continuously 3 days after OBX. Cognitive performance of the animals was analyzed by the novel object recognition test, modified Y maze test, and fear conditioning test. Brain tissues of OBX animals were used for neurochemical and immunohistochemical studies. OBX impaired non-spatial short-term memory, spatial working memory, and long-term fair memory. BM administration ameliorated these memory disturbances. The effect of BM on short-term memory deficits was abolished by a muscarinic receptor antagonist, scopolamine. OBX downregulated phosphorylation of synaptic plasticity-related signaling proteins: NR1 subunit of N-methyl-D-aspartate receptor, glutamate receptor 1 (GluR1), and calmodulin-dependent kinase II but not cyclic AMP-responsive element binding protein (CREB), and reduced brain-derived neurotrophic factor (BDNF) mRNA in the hippocampus. OBX also reduced choline acetyltransferase in the hippocampus and cholinergic neurons in the medial septum, and enlarged the size of lateral ventricle. BM administration reversed these OBX-induced neurochemical and histological alterations, except the decrease of GluR1 phosphorylation, and enhanced CREB phosphorylation. Moreover, BM treatment inhibited ex vivo activity of acetylcholinesterase in the brain. These results indicate that BM treatment ameliorates OBX-induced cognition dysfunction via a mechanism involving enhancement of synaptic plasticity-related signaling and BDNF transcription and protection of cholinergic systems from OBX-induced neuronal damage.


Subject(s)
Bacopa/chemistry , Memory Disorders/drug therapy , Olfactory Bulb/physiology , Plant Extracts/therapeutic use , Acetylcholinesterase/metabolism , Acoustic Stimulation , Animals , Choline O-Acetyltransferase/biosynthesis , Choline O-Acetyltransferase/metabolism , Fear , Male , Maze Learning/drug effects , Mice , Neuronal Plasticity/drug effects , Phytotherapy , Scopolamine/pharmacology , Signal Transduction/drug effects
18.
ScientificWorldJournal ; 2013: 309143, 2013.
Article in English | MEDLINE | ID: mdl-24235882

ABSTRACT

Nutritional deficiency can cause, mainly in chronic alcoholic subjects, the Wernicke encephalopathy and its chronic neurological sequela, the Wernicke-Korsakoff syndrome (WKS). Long-term chronic ethanol abuse results in hippocampal and cortical cell loss. Thiamine deficiency also alters principally hippocampal- and frontal cortical-dependent neurochemistry; moreover in WKS patients, important pathological damage to the diencephalon can occur. In fact, the amnesic syndrome typical for WKS is mainly due to the damage in the diencephalic-hippocampal circuitry, including thalamic nuclei and mammillary bodies. The loss of cholinergic cells in the basal forebrain region results in decreased cholinergic input to the hippocampus and the cortex and reduced choline acetyltransferase and acetylcholinesterase activities and function, as well as in acetylcholine receptor downregulation within these brain regions. In this narrative review, we will focus on the neurochemical, neuroanatomical, and neuropsychological studies shedding light on the effects of thiamine deficiency in experimental models and in humans.


Subject(s)
Diencephalon/metabolism , Hippocampus/metabolism , Korsakoff Syndrome/metabolism , Thiamine Deficiency/metabolism , Wernicke Encephalopathy/metabolism , Acetylcholinesterase/biosynthesis , Animals , Choline O-Acetyltransferase/biosynthesis , Diencephalon/pathology , Down-Regulation , Hippocampus/pathology , Humans , Korsakoff Syndrome/pathology , Receptors, Cholinergic/biosynthesis , Thiamine Deficiency/pathology , Wernicke Encephalopathy/pathology
19.
Biochem Biophys Res Commun ; 427(3): 531-6, 2012 Oct 26.
Article in English | MEDLINE | ID: mdl-23022191

ABSTRACT

Olig2 protein, a member of the basic helix-loop-helix transcription factor family, was introduced into the mouse embryonic carcinoma cell line P19 for induction of motor neuron differentiation. We show that Olig2 protein has the ability to permeate the cell membrane without the addition of a protein transduction domain (PTD), similar to other basic helix-loop-helix transcription factors such as MyoD and NeuroD2. Motor neuron differentiation was evaluated for the elongation of neurites and the expression of choline acetyltransferase (ChAT) mRNA, a differentiation marker of motor neurons. By addition of Olig2 protein, motor neuron differentiation was induced in P19 cells.


Subject(s)
Basic Helix-Loop-Helix Transcription Factors/metabolism , Motor Neurons/cytology , Nerve Tissue Proteins/metabolism , Neurogenesis/physiology , Animals , Basic Helix-Loop-Helix Transcription Factors/genetics , Basic Helix-Loop-Helix Transcription Factors/pharmacology , Cell Line, Tumor , Choline O-Acetyltransferase/biosynthesis , Mice , Motor Neurons/drug effects , Motor Neurons/metabolism , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/pharmacology , Neurites/metabolism , Neurites/physiology , Neurogenesis/drug effects , Oligodendrocyte Transcription Factor 2 , Protein Structure, Tertiary , Protein Transport , RNA, Messenger/biosynthesis
20.
Eur Respir J ; 39(3): 698-704, 2012 Mar.
Article in English | MEDLINE | ID: mdl-21885397

ABSTRACT

Macrophages increase in number and are highly activated in chronic obstructive pulmonary disease (COPD). Muscarinic receptor antagonists inhibit acetylcholine-stimulated release of neutrophilic chemoattractants, suggesting that acetylcholine may regulate macrophage responses. Therefore, expression and function of components of the non-neuronal cholinergic system in monocyte-macrophage cells was investigated. RNA was isolated from monocytes, monocyte-derived macrophages (MDMs), lung and alveolar macrophages from nonsmokers, smokers and COPD patients, and expression of the high-affinity choline transporter, choline acetyltransferase, vesicular acetylcholine transporter and muscarinic receptors (M(1)-M(5)) ascertained using real-time PCR. M(2) and M(3) receptor expression was confirmed using immunocytochemistry. Release of interleukin (IL)-8, IL-6 and leukotriene (LT)B(4) were measured by ELISA or EIA. All monocyte-macrophage cells expressed mRNA for components of the non-neuronal cholinergic system. Lung macrophages expressed significantly more M(1) mRNA compared with monocytes, and both lung macrophages and alveolar macrophages expressed the highest levels of M(3) mRNA. Expression of M(2) and M(3) protein was confirmed in MDMs and lung macrophages. Carbachol stimulated release of LTB(4) from lung macrophages (buffer 222.3 ± 75.1 versus carbachol 1,118 ± 622.4 pg · mL(-1); n = 15, p<0.05) but not IL-6 or IL-8. LTB(4) release was attenuated by the M(3) antagonist, 1,1-dimethyl-4-diphenylacetoxypiperidinium iodide (4-DAMP; half maximal effective concentration 5.2 ± 2.2 nM; n = 9). Stimulation of macrophage M(3) receptors promotes release of LTB(4), suggesting that anti-muscarinic agents may be anti-inflammatory.


Subject(s)
Macrophages/metabolism , Receptors, Muscarinic/biosynthesis , Carbachol/pharmacology , Cells, Cultured , Choline O-Acetyltransferase/biosynthesis , Humans , Interleukin-6/metabolism , Interleukin-8/metabolism , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/metabolism , Leukotriene B4/metabolism , Macrophages/drug effects , Membrane Transport Proteins/biosynthesis , Muscarinic Agonists/pharmacology , Muscarinic Antagonists/pharmacology , Piperidines/pharmacology , Pulmonary Disease, Chronic Obstructive/metabolism , RNA/analysis , Smoking/metabolism , Vesicular Acetylcholine Transport Proteins/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL